Bulletin
Investor Alert

Zynerba Pharmaceuticals Inc.

NAS: ZYNE

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204500323/composite

$

4.41

Change

-0.03 -0.68%

Volume

Volume 128,283

Aug 3, 2021, 7:33 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204500323/composite

Today's close

$ 4.50

$ 4.44

Change

-0.06 -1.33%

Day low

Day high

$4.36

$4.51

Open
Open: 4.50

52 week low

52 week high

$3.15

$9.00

Open

Market cap

$185.63M

Average volume

1.14M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.62

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/zyne

MarketWatch News on ZYNE

  1. Keep riding the stock market’s momentum — cautiously

    11:51 a.m. Feb. 18, 2021

    - Lawrence G. McMillan

  2. Watch the warnings coming from the stock market’s sell signals

    11:47 a.m. Feb. 4, 2021

    - Lawrence G. McMillan

  3. How to make, and avoid losing, money with marijuana stocks

    3:01 p.m. July 24, 2018

    - Nigam Arora

  4. Tech rally leads stocks higher; trade and Fed minutes also in focus

    4:27 p.m. July 5, 2018

    - Barbara Kollmeyer

  5. Zynerba says it now has enough cash to last until second half of 2019

    7:36 a.m. July 5, 2018

    - Ciara Linnane

  6. Zynerba shares slide 4.6% premarket

    7:36 a.m. July 5, 2018

    - Ciara Linnane

  7. Zynerba Pharma says study of cannabinoid skin patch did not meet goals

    7:35 a.m. July 5, 2018

    - Ciara Linnane

  8. Zynerba will now focus efforts on epilepsy program

    7:36 a.m. July 5, 2018

    - Ciara Linnane

  9. Zynerba Pharmaceuticals downgraded to perform from outperform at Oppenheimer

    7:57 a.m. Aug. 15, 2017

    - Tomi Kilgore

  10. Zynerba Pharmaceuticals downgraded to hold from buy at Maxim Group

    1:44 p.m. Aug. 7, 2017

    - Tomi Kilgore

  11. GW Pharma shares surge 2.7% after Zynerba Pharma's failed cannabidiol gel trial

    9:38 a.m. Aug. 7, 2017

    - Emma Court

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/zyne

Other News on ZYNE

  1. 10-Q: ZYNERBA PHARMACEUTICALS, INC.

    7:33 a.m. May 12, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  2. Zynerba Pharmaceuticals EPS beats by $0.05

    6:55 a.m. May 12, 2021

    - Seeking Alpha

  3. Zynerba: Repeated Trial Failures, Some Post Hoc Success

    11:22 a.m. April 13, 2021

    - Seeking Alpha

  4. Inside the Top-Performing ETFs of Q1

    12:15 p.m. March 31, 2021

    - Zacks.com

  5. SVRA, ZYNE, CANF and CLSK among midday movers

    12:41 p.m. March 16, 2021

    - Seeking Alpha

  6. GameStop, FuelCell Energy leads the premarket losers' pack

    8:19 a.m. March 16, 2021

    - Seeking Alpha

  7. 10-K: ZYNERBA PHARMACEUTICALS, INC.

    8:18 a.m. March 10, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  8. APHA, TLRY, OGI and ZYNE among notable midday movers

    1:39 p.m. Feb. 11, 2021

    - Seeking Alpha

  9. ZYNE Stock: Why Zynerba Pharmaceutical Shares Are Soaring Today

    5:12 p.m. Feb. 10, 2021

    - InvestorPlace.com

  10. Marijuana as medicine: the other cannabinoid pharma players

    5:00 p.m. Feb. 6, 2021

    - Seeking Alpha

  11. TLRY, GWPH, SSL and DGNR among premarket gainers

    9:31 a.m. Feb. 3, 2021

    - Seeking Alpha

  12. Zeroing In On Zynerba Pharmaceuticals

    6:33 p.m. Jan. 25, 2021

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/zyne

Press Releases on ZYNE

  1. Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting

    7:00 a.m. June 30, 2021

    - GlobeNewswire

  2. Notice of Settlement of Derivative Actions

    8:09 a.m. May 26, 2021

    - GlobeNewswire

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.